Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Status:
Not yet recruiting
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to assess the feasibility and safety of administering a single
dose of psilocybin to patients diagnosed with alcohol use disorder (AUD). In addition the
investigators will establish the pharmacokinetic properties of the active metabolite
psilocin. This is the first step in a research project that has the overall aim to evaluate
the efficacy of a single administration of psilocybin as an intervention for treatment of
AUD.
Phase:
Phase 2
Details
Lead Sponsor:
Anders Fink-Jensen, MD, DMSci
Collaborator:
The Neurobiology Research Unit at Copenhagen University Hospital Rigshospitalet